BIOTECH SYNERGY, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

  • No Technology to Display

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

  • No Recent Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2007/0020,327 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsAbandonedMay 05, 06Jan 25, 07[A61K]
2006/0094,649 Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositionsAbandonedDec 10, 03May 04, 06[A61K, C07K]
2005/0196,403 Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsAbandonedFeb 07, 05Sep 08, 05[A61K, C07K]
2004/0146,519 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositionsAbandonedOct 22, 02Jul 29, 04[A61K]
2004/0121,946 Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositionsAbandonedOct 24, 02Jun 24, 04[A61K]
2004/0053,822 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositionsAbandonedOct 21, 02Mar 18, 04[A61K, C07K]
2004/0048,790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsAbandonedNov 18, 02Mar 11, 04[A61K, C07K]
2004/0037,843 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsAbandonedJan 14, 03Feb 26, 04[A61K, C07K]
2003/0224,036 Hla class I a2 tumor associated antigen peptides and vaccine compositionsAbandonedOct 15, 02Dec 04, 03[A61K]
5662907 Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopesExpiredJan 25, 94Sep 02, 97[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.